| The immune response during acute HIV-1 infection: clues for vaccine development AJ McMichael, P Borrow, GD Tomaras, N Goonetilleke, BF Haynes Nature Reviews Immunology 10 (1), 11-23, 2010 | 1155 | 2010 |
| The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection N Goonetilleke, MKP Liu, JF Salazar-Gonzalez, G Ferrari, E Giorgi, ... Journal of experimental medicine 206 (6), 1253-1272, 2009 | 824 | 2009 |
| Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study AC Hayward, EB Fragaszy, A Bermingham, L Wang, A Copas, ... The Lancet Respiratory Medicine 2 (6), 445-454, 2014 | 484 | 2014 |
| Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a … NP Goonetilleke, H McShane, CM Hannan, RJ Anderson, RH Brookes, ... The Journal of Immunology 171 (3), 1602-1609, 2003 | 471 | 2003 |
| Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA-and … N Goonetilleke, S Moore, L Dally, N Winstone, I Cebere, A Mahmoud, ... Journal of virology 80 (10), 4717-4728, 2006 | 258 | 2006 |
| Natural T cell–mediated protection against seasonal and pandemic influenza. Results of the flu watch cohort study AC Hayward, L Wang, N Goonetilleke, EB Fragaszy, A Bermingham, ... American journal of respiratory and critical care medicine 191 (12), 1422-1431, 2015 | 255 | 2015 |
| Vertical T cell immunodominance and epitope entropy determine HIV-1 escape MKP Liu, N Hawkins, AJ Ritchie, VV Ganusov, V Whale, S Brackenridge, ... The Journal of clinical investigation 123 (1), 2012 | 214 | 2012 |
| Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis A Williams, GJ Hatch, SO Clark, KE Gooch, KA Hatch, GA Hall, K Huygen, ... Tuberculosis 85 (1-2), 29-38, 2005 | 208 | 2005 |
| Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency NM Archin, JL Kirchherr, JAM Sung, G Clutton, K Sholtis, Y Xu, B Allard, ... The Journal of clinical investigation 127 (8), 3126-3135, 2017 | 205 | 2017 |
| A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria … SJ Dunachie, M Walther, JE Epstein, S Keating, T Berthoud, L Andrews, ... Infection and immunity 74 (10), 5933-5942, 2006 | 204 | 2006 |
| The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation MR Abrahams, SB Joseph, N Garrett, L Tyers, M Moeser, N Archin, ... Science translational medicine 11 (513), eaaw5589, 2019 | 182 | 2019 |
| Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection VV Ganusov, N Goonetilleke, MKP Liu, G Ferrari, GM Shaw, ... Journal of virology 85 (20), 10518-10528, 2011 | 177 | 2011 |
| Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials H McShane, AA Pathan, CR Sander, NP Goonetilleke, HA Fletcher, ... Tuberculosis 85 (1-2), 47-52, 2005 | 177 | 2005 |
| Protective Immunity against Mycobacterium tuberculosis Induced by Dendritic Cells Pulsed with both CD8+- and CD4+-T-Cell Epitopes from Antigen 85A H McShane, S Behboudi, N Goonetilleke, R Brookes, AVS Hill Infection and immunity 70 (3), 1623-1626, 2002 | 177 | 2002 |
| Curing HIV: seeking to target and clear persistent infection DM Margolis, NM Archin, MS Cohen, JJ Eron, G Ferrari, JV Garcia, ... Cell 181 (1), 189-206, 2020 | 142 | 2020 |
| Cellular immune responses induced in cattle by heterologous prime–boost vaccination using recombinant viruses and bacille Calmette–Guérin HM Vordermeier, SG Rhodes, G Dean, N Goonetilleke, K Huygen, ... Immunology 112 (3), 461-470, 2004 | 140 | 2004 |
| Clinical experience with plasmid DNA-and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction T Hanke, AJ McMichael, L Dorrell Journal of general virology 88 (1), 1-12, 2007 | 137 | 2007 |
| Boosting with Poxviruses Enhances Mycobacterium bovis BCG Efficacy against Tuberculosis in Guinea Pigs A Williams, NP Goonetilleke, H McShane, SO Clark, G Hatch, SC Gilbert, ... Infection and immunity 73 (6), 3814-3816, 2005 | 122 | 2005 |
| Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection G Ferrari, B Korber, N Goonetilleke, MKP Liu, EL Turnbull, ... PLoS pathogens 7 (2), e1001273, 2011 | 121 | 2011 |
| Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable JP Barton, N Goonetilleke, TC Butler, BD Walker, AJ McMichael, ... Nature communications 7 (1), 11660, 2016 | 106 | 2016 |
